New research in cloned pigs with a mutation of the SORL1 sheds light on Alzheimer's development. The findings could pave the way for new treatments for the neurodegenerative disorder.
Synthesizing a human embryo from stem cells and using gene editing to insert the Huntingtin gene, researchers found the mutation affected the size of germ layers compared to the control embryos. Findings suggest Huntington's disease may be a neurodevelopmental disorder that presents as a neurodegenerative disease later
A new study is set to discover precisely which aspects of social behavior androgens regulate and how they do it.
Using CRISPR gene editing, researchers introduce the SHANK3 gene variant into macaque monkeys. SHANK3 has previously been linked to autism in humans. The monkeys with the SHANK3 mutations exhibited behavioral traits and brain activity patterns similar to those seen in humans on the autism spectrum, Researchers hope the new model will facilitate new avenues of research for ASD.
Researchers will present their latest findings regarding genes associated with autism spectrum disorder in an upcoming meeting.
Using CRISPR-Cas9 gene editing, researchers identified actionable pathways responsible for the growth of glioblastoma stem cells. By reverse engineering brain cancer cells, multiple potential new targets for cancer treatments have been uncovered.
Researchers re-purposed CRISPR gene editing technology to study genes targeted by particular antibiotics. The study sheds light on how pharmacologists can improve existing antibiotics and develop new ones.
Using CRISPR techniques, researchers have uncovered a genetic network linked to autism.
The most common messenger RNA modification in mammals helps coordinate nerve cell response to memory inducting stimulus, a new study reveals.
With the aid of CRISPR gene editing techniques, researchers have identified a new biomarker for Alzheimer's disease. The study reports a deficiency of the protein STIM1 could be implicated in the sporadic version of the neurodegenerative disease.
Researchers use CRISPR gene editing technology to target GABA receptors in order to help treat mood disorders.
Researchers have successfully reduced some symptoms associated with fragile X syndrome in mice with the help of CRISPR-Cas 9 gene editing.
